The Management of Traumatic Optic Neuropathy: A Systematic Review and Meta-Analysis
学术急诊医学档案,
卷 13 编号 1 (2025),
6 九月 2025
,
第 e19 页
https://doi.org/10.22037/aaemj.v13i1.2453
摘要
Introduction: Traumatic optic neuropathy (TON) is a serious condition resulting from optic nerve injury, often due to head trauma. This study systematically reviews the existing literature to evaluate the effectiveness of various treatments in improving visual outcomes in TON patients.
Methods: A comprehensive literature search was conducted across databases including Medline (via PubMed), Web of Science, Cochrane Library, and EMBASE from January 1992 to October 2024. Studies were selected based on inclusion criteria that focused on TON patients treated with corticosteroids, conservative therapy, erythropoietin therapy, or surgical interventions. Quality assessment of the included studies was performed using the Joanna Briggs Institute (JBI) Risk of Bias Tool for each design. Data extraction and quality assessment were performed by two independent reviewers, with a meta-analysis conducted to evaluate the pooled visual acuity (VA) improvement rates.
Results: A total of 23 studies were included, encompassing 1,851 patients with TON. The meta-analysis revealed a pooled VA improvement rate of 50.6% across all treatment modalities. Specifically, corticosteroid-only treatment resulted in a 56.2% improvement rate, while combined corticosteroid and surgical decompression showed a 42.9% improvement rate. Conservative therapy had a 47.8% improvement rate. The heterogeneity among studies was significant (I2= 89.9%), and no significant publication bias was detected. Subgroup analyses indicated varied outcomes, with some studies reporting better results with early intervention.
Conclusion: The treatment of TON remains challenging, with no single modality showing clear superiority. The corticosteroids and surgical interventions provide potential benefits; however, conservative therapy might be appropriate for certain cases. Future research should focus on optimizing treatment protocols and exploring new therapeutic options, such as erythropoietin to improve visual outcomes in TON patients.
- Traumatic optic neuropathy
- ton
- Corticosteroids
- steroids
- optic nerve decompession
##submission.howToCite##
参考
References:
Yu-Wai-Man P. Traumatic optic neuropathy—Clinical features and management issues. Taiwan journal of ophthalmology. 2015;5(1):3-8.
Chen B, Zhang H, Zhai Q, Li H, Wang C, Wang Y. Traumatic optic neuropathy: a review of current studies. Neurosurgical Review. 2022;45(3):1895-913.
Samardzic K, Samardzic J, Janjetovic Z, Samardzic I, Sekelj S, Latic-Hodzic L. Traumatic optic neuropathy-to treat or to observe? Acta Informatica Medica. 2012;20(2):131.
Kumar M, Kowsalya A, Narayanamoorthy J, Kumarasamy D, Balakrishnan H, Chaudhary S. Erythropoietin as a treatment option for indirect traumatic optic neuropathy: A pilot study. Indian Journal of Ophthalmology. 2023;71(1):235-40.
Lai Y-F, Lin T-Y, Ho P-K, Chen Y-H, Huang Y-C, Lu D-W. Erythropoietin in optic neuropathies: current future strategies for optic nerve protection and repair. International Journal of Molecular Sciences. 2022;23(13):7143.
Oh H-J, Yeo D-G, Hwang S-C. Surgical treatment for traumatic optic neuropathy. Korean Journal of Neurotrauma. 2018;14(2):55.
Yu‐Wai‐Man P, Griffiths PG. Steroids for traumatic optic neuropathy. Cochrane Database of Systematic Reviews. 2013(6):CD006032.
Steinsapir KD. Treatment of traumatic optic neuropathy with high-dose corticosteroid. Journal of neuro-ophthalmology. 2006;26(1):65-7.
Saxena R, Singh D, Menon V. Controversies in neuro-ophthalmology: steroid therapy for traumatic optic neuropathy. Indian journal of ophthalmology. 2014;62(10):1028-30.
Barker TH, Stone JC, Sears K, Klugar M, Tufanaru C, Leonardi-Bee J, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials. JBI evidence synthesis. 2023;21(3):494-506.
Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A, et al. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI evidence synthesis. 2020;18(10):2127-33.
Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. bmj. 2016;355:i4919
Barker TH, Habibi N, Aromataris E, Stone JC, Leonardi-Bee J, Sears K, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies. JBI Evidence Synthesis. 2024;22(3):378-88.
Gao Y, Li J, Ma H, Nie C, Lv X, Lin X, et al. Endoscopic trans‐ethmosphenoid optic canal decompression is an optimal choice to save vision for indirect traumatic optic neuropathy. Acta ophthalmologica. 2022;100(2):e491-e501.
Rajiniganth M, Gupta AK, Gupta A, Bapuraj JR. Traumatic optic neuropathy: visual outcome following combined therapy protocol. Archives of Otolaryngology–Head & Neck Surgery. 2003;129(11):1203-6.
Levin LA, Beck RW, Joseph MP, Seiff S, Kraker R, Group IONTS. The treatment of traumatic optic neuropathy: the International Optic Nerve Trauma Study. Ophthalmology. 1999;106(7):1268-77.
Cook MW, Levin LA, Joseph MP, Pinczower EF. Traumatic optic neuropathy: a meta-analysis. Archives of Otolaryngology–Head & Neck Surgery. 1996;122(4):389-92.
Mauriello JA, DeLuca J, Krieger A, Schulder M, Frohman L. Management of traumatic optic neuropathy--a study of 23 patients. Br J Ophthalmol. 1992;76(6):349-52.
Chou PI, Sadun AA, Chen YC, Su WY, Lin SZ, Lee CC. Clinical experiences in the management of traumatic optic neuropathy. Neuro-Ophthalmology. 1996;16(6):325-36.
Mariak Z, Obuchowska I, Mariak Z, Stankiewicz A, Ustymowicz A, Proniewska-Skrȩtek E. High-dose steroid therapy of traumatic optic neuropathy may fail to protect the optic nerve permanently. Neuro-Ophthalmology. 1999;21(4):255-60.
Mine S, Yamakami I, Yamaura A, Hanawa K, Ikejiri M, Mizota A, et al. Outcome of traumatic optic neuropathy. Comparison between surgical and nonsurgical treatment. Acta Neurochirurgica. 1999;141(1):27-30.
Kountakis SE, Maillard AA, El-Harazi SM, Longhini L, Urso RG. Endoscopic optic nerve decompression for traumatic blindness. Otolaryngol Head Neck Surg. 2000;123(1 Pt 1):34-7.
Kitthaweesin K, Yospaiboon Y. Dexamethasone and methylprednisolone in treatment of indirect traumatic optic neuropathy. J Med Assoc Thai. 2001;84(5):628-34.
Yip CC, Chng NW, Au Eong KG, Heng WJ, Lim TH, Lim WK. Low-dose intravenous methylprednisolone or conservative treatment in the management of traumatic optic neuropathy. Eur J Ophthalmol. 2002;12(4):309-14.
Hsieh CH, Kuo YR, Hung HC, Tsai HH, Jeng SF. Indirect traumatic optic neuropathy complicated with periorbital facial bone fracture. J Trauma. 2004;56(4):795-801.
Lee KF, Muhd Nor NI, Yaakub A, Wan Hitam WH. Traumatic optic neuropathy: a review of 24 patients. Int J Ophthalmol. 2010;3(2):175-8.
Emanuelli E, Bignami M, Digilio E, Fusetti S, Volo T, Castelnuovo P. Post-traumatic optic neuropathy: our surgical and medical protocol. Eur Arch Otorhinolaryngol. 2015;272(11):3301-9.
Sosin M, De La Cruz C, Mundinger GS, Saadat SY, Nam AJ, Manson PN, et al. Treatment Outcomes following Traumatic Optic Neuropathy. Plast Reconstr Surg. 2016;137(1):231-8.
Pokharel S, Sherpa D, Shrestha R, Shakya K, Shrestha R, Malla OK, et al. Visual Outcome after Treatment with High Dose Intravenous Methylprednisolone in Indirect Traumatic Optic Neuropathy. J Nepal Health Res Counc. 2016;14(32):1-6.
Sefi-Yurdakul N, Koç F. Risk factors affecting the visual outcome in patients with indirect traumatic optic neuropathy. Int Ophthalmol. 2018;38(4):1647-52.
Kashkouli MB, Yousefi S, Nojomi M, Sanjari MS, Pakdel F, Entezari M, et al. Traumatic optic neuropathy treatment trial (TONTT): open label, phase 3, multicenter, semi-experimental trial. Graefes Arch Clin Exp Ophthalmol. 2018;256(1):209-18.
Chen HH, Lee MC, Tsai CH, Pan CH, Lin YT, Chen CT. Surgical Decompression or Corticosteroid Treatment of Indirect Traumatic Optic Neuropathy: A Randomized Controlled Trial. Annals of plastic surgery. 2020;84(1S Suppl 1):S80-S3.
Yu B, Ma YJ, Tu YH, Wu WC. Newly onset indirect traumatic optic neuropathy-surgical treatment first versus steroid treatment first. International Journal of Ophthalmology. 2020;13(1):124-8.
John A, Kakkanatt ACV, Mathai MT, Palatty BU, Kurian N, Sasidharan A. Traumatic optic neuropathy: Early detection and intervention in a tertiary care centre. Journal of Clinical and Diagnostic Research. 2020;14(4):NC05-NC8.
Gao Y, Li J, Ma H, Nie C, Lv X, Lin X, et al. Endoscopic trans-ethmosphenoid optic canal decompression is an optimal choice to save vision for indirect traumatic optic neuropathy. Acta Ophthalmol. 2022;100(2):e491-e501.
Wei W, Zhao SF, Li Y, Zhang JL, Wu JP, Liu HC, et al. The outcome of surgical and non-surgical treatments for traumatic optic neuropathy: a comparative study of 685 cases. Ann Transl Med. 2022;10(10):542.
Yang WG, Chen CT, Tsay PK, de Villa GH, Tsai YJ, Chen YR. Outcome for traumatic optic neuropathy--surgical versus nonsurgical treatment. Ann Plast Surg. 2004;52(1):36-42.
Challa NK, Aldakhil S. Clinical Spectrum of Indirect Traumatic Optic Neuropathy in South Indian Subjects Observational Study. Open Ophthalmology Journal. 2023;17(1): e187436412301040.
- 摘要 ##plugins.themes.ojsPlusA.frontend.article.viewed##: 453 ##plugins.themes.ojsPlusA.frontend.article.times##
- pdf (English) ##plugins.themes.ojsPlusA.frontend.article.downloaded##: 1212 ##plugins.themes.ojsPlusA.frontend.article.times##
##plugins.themes.ojsPlusA.frontend.article.downloadstatastics##
##plugins.block.makeSubmission.linkLabel##
SJR
COPE
